Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Zypadhera

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

94 API Suppliers, 35 USDMF, 24 CEP/COS, 15 JDMF, 16 EU WC, 13 KDMF, 20 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

85 Drugs in Development

85 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1466 FDF Dossiers, 223 FDA Orange Book, 891 Europe, 108 Canada, 55 Australia, 65 South Africa, 124 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 15MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET;ORAL - 7.5MG, TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG, TABLET, ORALLY DISINTEGRATING;ORAL - 20MG, TABLET, ORALLY DISINTEGRATING;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Rochem International Inc, 21 SPI Pharma, 14 DKSH, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Capital Farma, 1 Kirsch Pharma, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 30 BASF, 1 Bioplus Life Sciences, 3 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 16 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 45 Direct Compression, 39 Thickeners and Stabilizers, 36 Solubilizers, 34 Granulation, 33 Disintegrants & Superdisintegrants, 29 Taste Masking, 25 Topical, 25 Controlled & Modified Release, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 21 Parenteral, 18 Film Formers & Plasticizers, 13 Co-Processed Excipients, 13 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

91 News #PharmaBuzz

91 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 296 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

20 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents, 4 US Exclusivities, 26 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 21 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	TAPI Technology & API Services	Israel	TAPI NL B.V. Amsterdam NL	CEP 2024-297 - Rev 01	Olanzapine, Form II, micronised	2025-05-26	Valid	Chemical		2258
29/11/2025	TAPI Technology & API Services	Israel	TAPI NL B.V. Amsterdam NL	CEP 2012-161 - Rev 04	Olanzapine	2025-03-19	Valid	Chemical		2258

Zypadhera

Zypadhera

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

94 API Suppliers

35 USDMF

24 CEP/COS

15 JDMF

16 EU WC

13 KDMF

20 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

85 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1466 FDF Dossiers

223 FDA Orange Book

891 Europe

108 Canada

55 Australia

65 South Africa

124 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 15MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET;ORAL - 7.5MG

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG

TABLET, ORALLY DISINTEGRATING;ORAL - 15MG

TABLET, ORALLY DISINTEGRATING;ORAL - 20MG

TABLET, ORALLY DISINTEGRATING;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Rochem International Inc

21 SPI Pharma

14 DKSH

1 Pharm-RX Chemical

5 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 Capital Farma

1 Kirsch Pharma

4 ACG Worldwide

9 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

30 BASF

1 Bioplus Life Sciences

3 Clariant

11 Corel Pharma Chem

5 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

3 Finar

12 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq